IMAGING TUMOR VARIATION IN RESPONSE TO PHOTODYNAMIC THERAPY IN PANCREATIC CANCER XENOGRAFT MODELS

被引:46
|
作者
Samkoe, Kimberley S. [1 ]
Chen, Alina [1 ]
Rizvi, Imran [1 ,2 ]
O'Hara, Julia A. [1 ]
Hoopes, P. Jack [1 ,3 ]
Pereira, Stephen P. [4 ]
Hasan, Tayyaba [2 ]
Pogue, Brian W. [1 ,2 ,3 ]
机构
[1] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03766 USA
[2] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
[3] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Surg, Hanover, NH 03756 USA
[4] UCL, Sch Med, Inst Hepatol, London W1N 8AA, England
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 76卷 / 01期
基金
美国国家卫生研究院;
关键词
Photodynamic therapy; Pancreatic cancer; Magnetic resonance imaging; Tumor aggressiveness; Orthotopic tumor; ENDOTHELIAL GROWTH-FACTOR; VERTEPORFIN; ADENOCARCINOMA; GEMCITABINE;
D O I
10.1016/j.ijrobp.2009.08.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: A treatment monitoring study investigated the differential effects of orthotopic pancreatic cancer models in response to interstitial photodynamic therapy (PDT), and the validity of using magnetic resonance imaging as a surrogate measure of response was assessed. Methods and Materials: Different orthotopic pancreatic cancer xenograft models (AsPC-1 and Panc-1) were used to represent the range of pathophysiology observed in human beings. Identical dose escalation studies (10, 20, and 40J/cm) using interstitial verteporfin PDT were performed, and magnetic resonance imaging with T2-weighted and T1-weighted contrast were used to monitor the total tumor volume and the vascular perfusion volume, respectively. Results: There was a significant amount of necrosis in the slower-growing Panc-1 tumor using high light dose, although complete necrosis was not observed. Lower doses were required for the same level of tumor kill in the faster-growing AsPC-1 cell line. Conclusions: The tumor growth rate and vascular pattern of the tumor affect the optimal PDT treatment regimen, with faster-growing tumors being relatively easier to treat. This highlights the fact that therapy in human beings shows a heterogeneous range of outcomes, and suggests a need for careful individualized treatment outcomes assessment in clinical work. (C) 2010 Elsevier Inc.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 50 条
  • [31] Multifunctional Nanostructures for Tumor-Targeted Molecular Imaging and Photodynamic Therapy
    Wu, Hao
    Wang, Huihui
    Liao, Han
    Lv, Yan
    Song, Xiaojie
    Ma, Xiaojun
    Tan, Mingqian
    ADVANCED HEALTHCARE MATERIALS, 2016, 5 (03) : 311 - 318
  • [32] Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo
    Liu, CD
    Kwan, D
    Saxton, RE
    McFadden, DW
    JOURNAL OF SURGICAL RESEARCH, 2000, 93 (01) : 137 - 143
  • [33] Role of Tumor Microenvironment on Gene Expression in Pancreatic Cancer Tumor Models
    Mees, Soeren Torge
    Mardin, Wolf Arif
    Schleicher, Christina
    Colombo-Benkmann, Mario
    Senninger, Norbert
    Haier, Joerg
    JOURNAL OF SURGICAL RESEARCH, 2011, 171 (01) : 136 - 142
  • [34] Effects of combined inhibition of MEK and mTOR on downstream signaling and tumor growth in pancreatic cancer xenograft models
    Chang, Qing
    Chen, Eric
    Hedley, David W.
    CANCER BIOLOGY & THERAPY, 2009, 8 (20) : 1893 - 1901
  • [35] Construction of orthotopic xenograft mouse models for human pancreatic cancer
    Dai, Lei
    Lu, Caide
    Yu, Xi
    Dai, Long-Jun
    Zhou, Jeff X.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (03) : 1033 - 1038
  • [36] Huachansu injection inhibits metastasis of pancreatic cancer in mice model of human tumor xenograft
    Yin, Jian-Hua
    Zhu, Xiao-Yan
    Shi, Wei-Dong
    Liu, Lu-Ming
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [37] Phthalocyanine labeled LDL for tumor imaging and photodynamic therapy
    Li, H
    Marotta, D
    Kim, SK
    Chance, B
    Glickson, J
    Busch, TM
    Zheng, G
    OPTICS IN HEALTH CARE AND BIOMEDICAL OPTICS: DIAGNOSTICS AND TREATMENT II , PTS 1 AND 2, 2005, 5630 : 8 - 15
  • [38] Pathological tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer
    Heinrich, Stefan
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (04) : 305 - 306
  • [39] Response to Preoperative Therapy in Localized Pancreatic Cancer
    Perri, Giampaolo
    Prakash, Laura R.
    Katz, Matthew H. G.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [40] Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell-line mouse models
    Hiroshima, Yukihiko
    Zhang, Yong
    Murakami, Takashi
    Maawy, Ali
    Miwa, Shinji
    Yamamoto, Mako
    Yano, Shuya
    Sato, Sho
    Momiyama, Masashi
    Mori, Ryutaro
    Matsuyama, Ryusei
    Chishima, Takashi
    Tanaka, Kuniya
    Ichikawa, Yasushi
    Bouvet, Michael
    Endo, Itaru
    Zhao, Ming
    Hoffman, Robert M.
    ONCOTARGET, 2014, 5 (23) : 12346 - 12357